A detailed history of Great West Life Assurance CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Great West Life Assurance CO holds 3,252,531 shares of BMY stock, worth $176 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,252,531
Previous 2,868,272 13.4%
Holding current value
$176 Million
Previous $156 Million 13.19%
% of portfolio
0.25%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $15.5 Million - $20.4 Million
384,259 Added 13.4%
3,252,531 $135 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $12.6 Million - $14.3 Million
263,109 Added 10.1%
2,868,272 $156 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $424,103 - $506,071
8,748 Added 0.34%
2,605,163 $133 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $514,526 - $575,320
-8,888 Reduced 0.34%
2,596,415 $151 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $6.35 Million - $7.05 Million
99,690 Added 3.98%
2,605,303 $168 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $2.94 Million - $3.33 Million
44,682 Added 1.82%
2,505,613 $174 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $4.24 Million - $5.02 Million
61,923 Added 2.58%
2,460,931 $178 Million
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $1,617 - $955,812
-12,439 Reduced 0.52%
2,399,008 $170 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $175 Million - $193 Million
2,411,447 New
2,411,447 $186 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $166 Million - $183 Million
-2,287,420 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $3.31 Million - $3.97 Million
53,815 Added 2.41%
2,287,420 $176 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $9.25 Million - $10.8 Million
-172,553 Reduced 7.17%
2,233,605 $139 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $6.23 Million - $7.3 Million
105,371 Added 4.58%
2,406,158 $143 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $2.7 Million - $2.94 Million
43,611 Added 1.93%
2,300,787 $154 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $29.3 Million - $32.9 Million
-493,601 Reduced 17.94%
2,257,176 $142 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $9.93 Million - $11.2 Million
-171,938 Reduced 5.88%
2,750,777 $170 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $9.55 Million - $10.6 Million
-166,270 Reduced 5.38%
2,922,715 $176 Million
Q2 2020

Aug 17, 2020

SELL
$54.82 - $64.09 $24.9 Million - $29.1 Million
-454,202 Reduced 12.82%
3,088,985 $181 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $16.4 Million - $23.9 Million
354,270 Added 11.11%
3,543,187 $199 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $43.1 Million - $56.2 Million
874,847 Added 37.81%
3,188,917 $205 Million
Q3 2019

Oct 25, 2019

SELL
$42.77 - $50.71 $9.5 Million - $11.3 Million
-222,105 Reduced 8.76%
2,314,070 $117 Million
Q2 2019

Jul 31, 2019

BUY
$44.62 - $49.34 $45.7 Million - $50.5 Million
1,023,915 Added 67.71%
2,536,175 $0
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $10.1 Million - $12.1 Million
224,370 Added 17.42%
1,512,260 $72 Million
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $37.5 Million - $48.6 Million
-768,533 Reduced 37.37%
1,287,890 $63.9 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $10.2 Million - $11.5 Million
-184,050 Reduced 8.21%
2,056,423 $128 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $18.4 Million - $23 Million
364,494 Added 19.43%
2,240,473 $124 Million
Q1 2018

May 10, 2018

SELL
$59.92 - $68.98 $4.74 Million - $5.46 Million
-79,172 Reduced 4.05%
1,875,979 $119 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $28.5 Million - $31.1 Million
475,602 Added 32.15%
1,955,151 $120 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $81.7 Million - $94.3 Million
1,479,549
1,479,549 $93.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.